Neonatal SARS-CoV-2 Anti-spike Protein Receptor-binding Domain Antibodies at Delivery
NCT05564884 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 58
Last updated 2022-10-04
Summary
To assess the association between neonatal SARS-CoV-2 antibody level at delivery and infant COVID-19 infection under age 6 months, and to identify predictive factors for neonatal antibody level at delivery.
Conditions
Interventions
- OTHER
-
no intervantion
no intervention
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Principal Investigators
-
Liat Ashkenazi-Hoffnung · Schneider children medical center
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-12
- Primary Completion
- 2022-02-24
- Completion
- 2022-11-01
Countries
- Israel
Study Locations
More Related Trials
-
Mucosal Immunity in Terms of SARS-CoV-2 Antibodies in Saliva After COVID-19 Infection and Vaccination
NCT04842305 ·Status: UNKNOWN
-
Mother to Child Transmission of Antibody to Covid-19 The TRAB CoV-19 Study.
NCT05305261 ·Status: COMPLETED
-
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
NCT04659759 ·Status: COMPLETED
-
Salivary Profiling in Infants Treated for Suspected Sepsis: The SPITSS Study
NCT05490212 ·Status: UNKNOWN
-
COPE - COVID-19 in Pregnancy and Early Childhood
NCT04433364 ·Status: ACTIVE_NOT_RECRUITING
-
COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C
NCT04588363 ·Status: COMPLETED
-
Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection
NCT04362956 ·Status: COMPLETED
-
Transplacental Transmission of COVID-19
NCT05124574 ·Status: TERMINATED
-
Infant Immune Response to Bacterial Infection
NCT00546195 ·Status: COMPLETED
-
In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life
NCT04921241 ·Status: COMPLETED
-
Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months
NCT00800488 ·Status: COMPLETED
-
COVID Booster in Pregnancy and Lactation
NCT05543993 ·Status: COMPLETED
-
Transfusion-Transmitted Cytomegalovirus Prevention in Neonates
NCT00000584 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility Study for Identifying Anti Capsular Antibody Protection Against Invasive Group B Streptococcus (GBS) Disease in Newborns of 0-6 Days Age (Early Onset Disease [EOD]) as Well as Among Infants of 7-90 Days Age (Late Onset Disease [LOD])
NCT01888471 ·Status: COMPLETED ·Phase: NA
-
Comparing Infectious Morbidity Among Women With Meconium-stained Amniotic Fluid at Term, Between Those Treated With Prophylactic Antibiotics Zinacef vs. Placebo
NCT06849037 ·Status: RECRUITING ·Phase: NA
-
Salivary C- Reactive Protein, Mean Platelet Volume and Neutrophil Lymphocyte Ratio as Diagnostic Markers for Neonatal Sepsis
NCT04800445 ·Status: UNKNOWN
-
Investigation of the Passage of Antiviral Antibodies From Mother to Child
NCT05821764 ·Status: UNKNOWN
-
Maternal-foetal Transmission of SARS-Cov-2
NCT04395924 ·Status: COMPLETED
-
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
NCT04388605 ·Status: ACTIVE_NOT_RECRUITING
-
Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Infants Aged Less Than 90 Days
NCT02099149 ·Status: WITHDRAWN
-
Neutrophil CD64 for Early Diagnosis of Nosocomial Infection in Preterm Newborns
NCT01951781 ·Status: UNKNOWN ·Phase: NA
-
Group B Strep Correlates of Protection Study
NCT06431217 ·Status: COMPLETED
-
Prenatal Antibiotics and Breast Milk / Neonatal IgA
NCT05813184 ·Status: RECRUITING
-
Evaluation of the Performance of the Covid-19 Ag BSS Rapid Antigenic Test in Symptomatic Children in a Pediatric Emergency Department
NCT04583189 ·Status: COMPLETED ·Phase: NA
-
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
NCT06592586 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3